Page results
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
-
Taking blood pressure medication in the evening is no better than taking it in the morning, according to new research.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
This page explains what a low-phosphate diet is. It also provides information about foods you can eat and foods to avoid when taking a medicine called futibatinib.
-
Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the 24-hour ambulatory blood pressure and heart rate (24-hr BP) monitor.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
Today is International Clinical Trials Day, an important day on the UCLH calendar because research is an integral part of UCLH’s mission.
File results
-
FOI/2023/0827 - Consultation on future of EDS services
-
FOI/2023/0829 - Immunoglobulin treatments
-
FOI/2023/0831 - Treatments for acute myeloid leukaemia/ chronic lymphocytic leukaemia
-
FOI/2023/0832 - Hospital admissions for vaping related disorders
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis
-
FOI/2023/0840 - Deaths in accident and emergency 2018-2023
-
FOI/2023/0842 - Acquired Brain Injury condition daily fees/ spend per patient
-
FOI/2023/0845 - Treatement for gastric and gastro-oesophageal junction/ Oesophageal/ ovarian cancers